Smith & Nephew Plc (SN.)-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8014345)
◆英語タイトル:Smith & Nephew Plc (SN.) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014345
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:67
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Smith & Nephew Plc (Smith & Nephew) develops, manufactures and markets medical devices for use in orthopedic reconstruction, orthopedic trauma and clinical therapies, sports medicines and advanced wound management. The company offers its products in various categories including Sports Medicine Joint Repair, Arthroscopic Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. It has manufacturing facilities and distribution centers in various parts of the world. The company sells its products in Europe, North America, Asia Pacific, the Middle East and Africa. Smith & Nephew is headquartered in London, the UK.

Smith & Nephew Plc (SN.) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Smith & Nephew Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Smith & Nephew Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Smith & Nephew Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Smith & Nephew Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Smith & Nephew Plc, Medical Devices Deals, 2011 to YTD 2017 11
Smith & Nephew Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Smith & Nephew Plc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Smith & Nephew Acquires Certain Assets from Plato 13
Healthpoint Biotherapeutics Acquires Regranex Gel From Systagenix 14
Private Equity 15
Elliott Management May Acquire Stake in Smith & Nephew 15
Partnerships 16
Smith & Nephew Enters into Agreement with Imperial College London 16
Smith & Nephew Forms Joint Venture With Essex Woodlands 17
Debt Offering 19
Smith & Nephew to Raise USD730 Million in Debt Placement of 3.1% Due 2022 19
Smith & Nephew to Raise USD70 Million in Debt Placement 20
Acquisition 21
Medtronic May Acquire Smith & Nephew 21
Smith & Nephew Completes Acquisition of ArthroCare for USD1.7 Billion 22
Smith & Nephew Completes Acquisition Of Healthpoint Biotherapeutics, Wound Care Company, For US$782 Million 24
Smith & Nephew Plc – Key Competitors 26
Smith & Nephew Plc – Key Employees 27
Smith & Nephew Plc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Joint Venture 31
Recent Developments 32
Financial Announcements 32
Nov 03, 2017: Smith & Nephew Third Quarter 2017 Trading Report 32
Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 33
May 05, 2017: Smith & Nephew 2017 First Quarter Trading Report 36
Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results 38
Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 43
Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results 45
May 05, 2016: Smith & Nephew 2016 First Quarter Trading Report 48
Feb 04, 2016: Smith & Nephew Fourth Quarter Trading and Full Year 2015 Results 49
Corporate Communications 53
Oct 09, 2017: Smith & Nephew: Notice of Chief Executive Officer’s intention to retire by end of 2018 53
Oct 09, 2017: Notice of Chief Executive Officer’s intention to retire by end of 2018 54
Oct 02, 2017: Smith & Nephew Announces Directorate Change 55
Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director 56
Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 57
Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew 58
Nov 30, 2016: Graham Baker appointed Chief Financial Officer 59
Jul 11, 2016: CFO to leave Smith & Nephew in early 2017 60
Legal and Regulatory 61
Oct 16, 2017: False Advertising by Smith & Nephew Can Put Patients At Risk of Pressure Ulcers, Molnlycke Lawsuit Alleges 61
Other Significant Developments 62
Nov 09, 2016: Enabling Improved Patient Outcomes with Smith & Nephew’s Pioneering Episode of Care Assurance Program 62
Mar 04, 2016: Smith & Nephew : Annual Financial Report 63
Appendix 67
Methodology 67
About GlobalData 67
Contact Us 67
Disclaimer 67

List of Tables
Smith & Nephew Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Smith & Nephew Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Smith & Nephew Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Smith & Nephew Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Smith & Nephew Plc, Deals By Therapy Area, 2011 to YTD 2017 9
Smith & Nephew Plc, Medical Devices Deals, 2011 to YTD 2017 11
Smith & Nephew Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Smith & Nephew Acquires Certain Assets from Plato 13
Healthpoint Biotherapeutics Acquires Regranex Gel From Systagenix 14
Elliott Management May Acquire Stake in Smith & Nephew 15
Smith & Nephew Enters into Agreement with Imperial College London 16
Smith & Nephew Forms Joint Venture With Essex Woodlands 17
Smith & Nephew to Raise USD730 Million in Debt Placement of 3.1% Due 2022 19
Smith & Nephew to Raise USD70 Million in Debt Placement 20
Medtronic May Acquire Smith & Nephew 21
Smith & Nephew Completes Acquisition of ArthroCare for USD1.7 Billion 22
Smith & Nephew Completes Acquisition Of Healthpoint Biotherapeutics, Wound Care Company, For US$782 Million 24
Smith & Nephew Plc, Key Competitors 26
Smith & Nephew Plc, Key Employees 27
Smith & Nephew Plc, Other Locations 28
Smith & Nephew Plc, Subsidiaries 28
Smith & Nephew Plc, Joint Venture 31

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Smith & Nephew Plc (SN.)-製薬・医療分野:企業M&A・提携分析(Smith & Nephew Plc (SN.) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆